The UK Competition Appeal Tribunal issues a key judgment on margin squeeze and rebates in the pharmaceutical sector (Healthcare at Home / Genzyme)

KEYWORDS
Reference

UK Competition Appeal Tribunal, Healthcare at Home / Genzyme, Case n° 1016/1/1/03, 29 September 2005

In Genzyme Limited v. OFT, 29 September 2005, the UK Competition Appeal Tribunal (the “CAT”) tackled the difficult question of how to bring an abusive margin squeeze to an end and to ensure it was not repeated. The background to the proceedings was that the OFT had issued a decision (Director General of Fair Trading, 27 March 2003, Decision n° CA98/3/03, Exclusionary behaviour by Genzyme Limited, Case CP/0488-01) finding that Genzyme had, since 2001, abused its dominant position contrary to the UK Competition Act 1998 Chapter II prohibition (Chapter II is

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • Freshfields Bruckhaus Deringer (London)
    Royaume-Uni 11 contributions 36149 visites
  • King’s College (London)
    Royaume-Uni 20 contributions 81120 visites

Citation

Alex Potter, Alison Jones, The UK Competition Appeal Tribunal issues a key judgment on margin squeeze and rebates in the pharmaceutical sector (Healthcare at Home / Genzyme), 29 septembre 2005, e-Competitions September 2005, Art. N° 400

Visites 6718

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues